PRDM1 and pancreatic adenocarcinoma: In conclusion, we applied bioinformatics analysis to study the role of PRDM1 in PAAD, we found that higher expression of PRDM1 was associated with a poorer prognosis in PAAD patients, and PRDM1was closely related to PAAD immunopathogenesis.